Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ)

CUSIP: 68217N105

Q3 2022 13F Holders as of 30 Sep 2022

Security identity
Security type / class
Equity / COMMON STOCK
Shares outstanding
55,351,475
Holder snapshot
Total 13F shares
42,604,506
Share change
+120,051
Total reported value
$230,915,000
Put/Call ratio
97%
Reported price per share
$5.42
Number of holders
40
Value change
+$907,410
Number of buys
16
Number of sells
16

Security key

68217N105

Report period

Q3 2022

Institutions

40

Top holders

10

OMGAQ full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2022 Previous quarter: Q2 2022

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
—
13D/G signal
—
Evidence rows
0
Latest as of
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
40
Shares
42,604,506
Rows available
40
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
44
Q3 2022 holders
40
Holder diff
-4
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .